Blog

18. One of the central causes of vWD is the inability of the patient’s __________ to adhere to the subendothelial surfaces following injury to the blood vessel.

18. One of the central causes of vWD is the inability of the patient’s __________ to adhere to the subendothelial surfaces following injury to the blood vessel.

5. Factor VIII:vWF is the carrier protein of the factor VIII complex and serves to concentrate __________ present in small amounts to the site of the injury.

20. Which diffuse pathologic form of coagulation results from an accentuated coagulation response leading to consumption of coagulation factors and platelets with subsequent fibrin thrombi throughout the microcirculation as well as the site of endothelial damage?

38. Which of the following is not one of the criteria recommended by the International Society on Thrombosis and Hemostasis for the diagnosis of LA?

20. Which diffuse pathologic form of coagulation results from an accentuated coagulation response leading to consumption of coagulation factors and platelets with subsequent fibrin thrombi throughout the microcirculation as well as the site of endothelial damage?

36. Acquired deficiencies of factor VII are associated with:

36. Acquired deficiencies of factor VII are associated with:

18. a2-Anti-plasmin inhibitor irreversibly binds to the __________ binding site on plasmin in a 1:1 molar ratio.

44. Which of the following has/have been used in the treatment of TTP?